| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| nelotanserin | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Sleep Disorders[MeSHID:D012893] Lewy Body Disease[MeSHID:D020961] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.87 | investigational | unknown |
| nelotanserin | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Sleep Disorders[MeSHID:D012893] Lewy Body Disease[MeSHID:D020961] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.87 | investigational | inverse agonist |
| nelotanserin | 5-ht 2a receptor | NA | Successful target | TTD , DGIDB | Sleep Disorders[MeSHID:D012893] Lewy Body Disease[MeSHID:D020961] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.87 | phase 2 | unknown |
| nelotanserin | 5-ht 2a receptor | NA | Successful target | TTD , DGIDB | Sleep Disorders[MeSHID:D012893] Lewy Body Disease[MeSHID:D020961] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.87 | phase 2 | inverse agonist |
| click here to return to the previous page | ||||||||